Pages that link to "Q28274593"
Jump to navigation
Jump to search
The following pages link to Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction (Q28274593):
Displaying 50 items.
- High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure (Q24610732) (← links)
- Prognostic biomarkers in acute coronary syndrome (Q26738521) (← links)
- State of the Art: Newer biomarkers in heart failure (Q27027899) (← links)
- Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial (Q28253329) (← links)
- ST2: a novel remodeling biomarker in acute and chronic heart failure (Q28280799) (← links)
- Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure (Q28294246) (← links)
- Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry (Q28395328) (← links)
- Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure. (Q30386714) (← links)
- Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome (Q30409730) (← links)
- Biomarkers in acute myocardial infarction. (Q33596823) (← links)
- Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients. (Q33711545) (← links)
- Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome (Q34032238) (← links)
- Soluble ST2, a modulator of the inflammatory response, in preterm and term labor (Q34164039) (← links)
- Daily exposure to dust alters innate immunity (Q34166427) (← links)
- Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes (Q34300880) (← links)
- The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure (Q34408467) (← links)
- Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? (Q34462325) (← links)
- Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial (Q34536010) (← links)
- Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. (Q34619975) (← links)
- The IL-33/ST2 pathway: therapeutic target and novel biomarker (Q34776884) (← links)
- Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact (Q35112353) (← links)
- Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome (Q35153947) (← links)
- Prognostic Impact of Early ST-Segment Resolution and Biochemical Markers in Patients With ST-Elevation Myocardial Infarction (Q35154432) (← links)
- Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community (Q35224090) (← links)
- Membrane translocation of IL-33 receptor in ventilator induced lung injury (Q35224970) (← links)
- Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction (Q35326877) (← links)
- Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. (Q35588992) (← links)
- Cardiovascular biomarkers in acute Kawasaki disease (Q35658781) (← links)
- Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis (Q35782067) (← links)
- Advancing cardiovascular biology and medicine via proteomics: Opportunities and present challenges of cardiovascular proteomics (Q36863226) (← links)
- Soluble ST2 protein in chronic heart failure is independent of traditional factors (Q36686088) (← links)
- Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study (Q36851584) (← links)
- Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction (Q36864318) (← links)
- Multimarker Risk Stratification in Patients With Acute Myocardial Infarction (Q36956650) (← links)
- Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load (Q37087572) (← links)
- Potential Markers in Cardiac Hypertrophy? (Q37155198) (← links)
- Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling (Q37200836) (← links)
- Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection (Q37363858) (← links)
- Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation (Q37449938) (← links)
- Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain. (Q37547780) (← links)
- ST2 in emergency department patients with noncardiac dyspnea. (Q37680118) (← links)
- Soluble ST2 predicts elevated SBP in the community (Q37702150) (← links)
- Early detection of myocardial dysfunction and heart failure (Q37748500) (← links)
- ST2: a novel biomarker for heart failure (Q37750852) (← links)
- B-type natriuretic peptides: looking to the future (Q37801667) (← links)
- The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease (Q37847675) (← links)
- Systems biology of heart failure, challenges and hopes (Q37863441) (← links)
- Novel biomarkers in human terminal heart failure and under mechanical circulatory support (Q37894731) (← links)
- Established and Novel Biomarkers in ST-elevation Myocardial Infarction (Q37907327) (← links)
- Role of IL-33 in inflammation and disease (Q37922810) (← links)